[Clinical use of hematopoietic growth factors].
Krusius
T
T
SPR Veripalvelu, Helsinki, Finland.
D000741:Anemia, Aplastic / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007378:Interleukins / Q000627:therapeutic use; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D009503:Neutropenia / Q000188:drug therapy
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors; D007378:Interleukins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Hematopoieettisten kasvutekijöiden kliininen käyttö.